AdaptHealth (AHCO)

The company reports its business through four main product-led segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home. Sleep Health is its largest revenue contributor and centers on treatment for obstructive sleep apnea, including continuous positive airway pressure (CPAP), BiLevel devices, masks, tubing, and recurring supplies. This segment benefits from the recurring nature of replacement supplies and the large diagnosed and undiagnosed population affected by sleep-disordered breathing.

AdaptHealth’s Respiratory Health activities include home oxygen and ventilation-related products for patients with respiratory disease, while Diabetes Health supplies products used in the monitoring and management of diabetes. Wellness at Home covers a broader set of home medical equipment and supplies intended to support mobility, recovery, and day-to-day patient care.

A key feature of AdaptHealth’s model is its scale across fragmented home medical equipment markets. The company works with patients, physicians, hospitals, payers, and manufacturers, aiming to make the transition from prescription to home use more efficient. For investors, AHCO represents exposure to the structural shift toward lower-cost home-based care and the demand for products tied to chronic disease management.